8:00 AM Eastern Program Overview
Chair: Ira M. Jacobson, MD
8:15 AM Eastern Interactive Plenary: HCV Treatment Options in 2017/2018: What’s Here and What’s Coming Soon
Faculty: Ira M. Jacobson, MD
8:45 AM Eastern Interactive Roundtable: Individualizing Initial HCV Therapy
Moderator: Jordan J. Feld, MD, MPH
Panel: Ira M. Jacobson, MD; Kristen Marks, MD; Mark S. Sulkowski, MD
9:45 AM Eastern Question and Answer Session
10:15 AM Eastern Interactive Plenary: Managing HCV DAA Failure
Faculty: David L. Wyles, MD
10:45 AM Eastern Interactive Roundtable: Challenging Patient Cases in HCV and HBV Infection
Moderator: Mark S. Sulkowski, MD
Panel: Jordan J. Feld, MD, MPH; Kristen Marks, MD; David L. Wyles, MD
11:45 AM Eastern Question and Answer Session
12:15 PM Eastern Adjournment
The primary purpose of this program is to arm clinicians with tools to address the most important and most current challenges in viral hepatitis management by providing a tightly focused update on recent advances and key clinical issues encountered in the clinic. The program will consist of 2 live half-day highly interactive workshops dedicated to viral hepatitis.
The goal of this activity is to improve participants’ competence in addressing the most important and most current challenges in viral hepatitis management by providing a tightly focused update on recent advances and key clinical issues encountered in the clinic.
This program is intended for infectious diseases clinicians, hepatologists, gastroenterologists, registered nurses, pharmacists, and other healthcare professionals involved in the care of patients with viral hepatitis.
Upon completion of this activity, participants should be able to:
- Integrate the results of clinical studies of approved viral hepatitis treatments into optimized patient management strategies
- Apply key guidelines and study data to ensure appropriate, individualized management for diverse patient populations with viral hepatitis infection, based on individual patient factors
- Implement practical strategies to optimize outcomes in patients receiving therapy for viral hepatitis
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program has been assigned ACPE Universal Activity #0797-9999-17-032-L01-P. This program is designated for up to 4.25 contact hours (.425 CEUs) of continuing pharmacy education credit.
Type of Activity: Knowledge
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
Nursing Continuing Education
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
4.2 contact hours may be earned for successful completion of this activity.
California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, Provider Number 13664, for 4.2 contact hours.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 4 weeks.
Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.